Celsion (CLSN) – FDA
-
Celsion (CLSN) Highlights PLACCINE Vaccine Platform Technology
-
Celsion (CLSN) Announces Data Safety Monitoring Board Recommends to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CLSN Stock Lookup